Monomethyl Fumarate Market In Global
Monomethyl Fumarate (CAS 2756-87-8), the active metabolite of the psoriasis drug Fumaderm, is a p ... Read More
Preladenant (CAS 377727-87-2) is a potent and selective antagonist at the adenosine A2A receptor.
This report contains market size and forecasts of Preladenant in global, including the following market information:
Global Preladenant Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Preladenant Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Preladenant companies in 2021 (%)
The global Preladenant market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Preladenant include Adooq Bioscience, Toronto Research Chemicals, TargetMol, BOC Sciences, Focus Biomolecules, Biosynth Carbosynth, Cayman Chemical, BLDpharm and InvivoChem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Preladenant manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preladenant Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Preladenant Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Preladenant Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Preladenant Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Preladenant Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Preladenant Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preladenant revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Preladenant revenues share in global market, 2021 (%)
Key companies Preladenant sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Preladenant sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adooq Bioscience
Toronto Research Chemicals
TargetMol
BOC Sciences
Focus Biomolecules
Biosynth Carbosynth
Cayman Chemical
BLDpharm
InvivoChem
AbMole
APExBIO Technology
Combi-Blocks
MuseChem
Aladdin
Taiclone
Monomethyl Fumarate (CAS 2756-87-8), the active metabolite of the psoriasis drug Fumaderm, is a p ... Read More
Acebilustat (CAS 943764-99-6), also known as ZK322, is a novel, oral, potent and selective leukot ... Read More
Dithranol (CAS 1143-38-0) is a hepsin activity inhibitor used for treatment of psoriasis. Dithran ... Read More
Zalcitabine (CAS 7481-89-2) is a nucleoside analog HIV reverse transcriptase inhibitor (NARTI). ... Read More